DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Relamorelin
Relamorelin
New Developments in Prokinetic Therapy for Gastric Motility Disorders
Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
( 12 ) United States Patent
2017 Research Annual Report Table of Contents Summaries of 2017
Gastroparesis: 2014
Gastrointestinal Symptoms in Diabetes: Prevalence, Assessment
Prucalopride in Gastroparesis: a Randomized Placebo-Controlled
Growth Hormone Secretagogues: History, Mechanism of Action and Clinical Development
(12) Patent Application Publication (10) Pub. No.: US 2016/0243197 A1 G00 Sens (43) Pub
Review Article
Assessment of Gastrointestinal Autonomic Dysfunction: Present and Future Perspectives
Diabetic Gastroparesis: Perspectives from a Patient and Health Care Providers
Pharmacologic, Pharmacokinetic, and Pharmacogenomic Aspects Of
Stembook 2018.Pdf
Gastroenterology
ACG 2014! the Premier GI Clinical Event of the Year!
PD Expertbriefing
Gastroparesis Research Consortium - Research Grant
Top View
Thèse Et Mémoire
WO 2015/069773 Al 14 May 2015 (14.05.2015) P O P C T
The Effects of Ulimorelin, a Ghrelin Agonist, on Liquid Gastric Emptying and Colonic Transit in Humans
RM-131) in Patients with Type 1 and Type 2 Diabetes Mellitus and Delayed Gastric Emptying
(12) Patent Application Publication (10) Pub. No.: US 2017/0172961 A1 HELLER Et Al
Treatment of Autonomic Dysfunction in Parkinson Disease and Other Synucleinopathies
Management of Slow Colonic Transit Constipation in Parkinson’S Disease: Current Evidence and a Community Pharmacy Perspective
Idiopathic Gastroparesis: Lifestyle Modifications Versus Pharmacotherapy
Presentazione Standard Di Powerpoint
Role of Relamorelin and Other Ghrelin Receptor Agonists
(12) Patent Application Publication (10) Pub. No.: US 2017/0121385 A1 Shah Et Al
Treatment of Autonomic Dysfunction in Parkinson Disease and Other Synucleinopathies
Spisak Roba Svrstanih Po Odlukama Komiteta Za Harmonizovani Sistem
Future Treatment of Constipation-Associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists
Annexes to the Annual Report of the European Medicines Agency 2020
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
INN-Nimet 1 1.7.2019 a Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum Abagovomabi Abaloparatide Abaloparatidum Abalopara
WO 2016/179540 Al 10 November 2016 (10.11.2016) P O P C T